Kimia Biosciences Balance Sheet Health
Financial Health criteria checks 4/6
Kimia Biosciences has a total shareholder equity of ₹3.9M and total debt of ₹573.6M, which brings its debt-to-equity ratio to 14872.7%. Its total assets and total liabilities are ₹1.0B and ₹1.0B respectively.
Key information
14,872.7%
Debt to equity ratio
₹573.64m
Debt
Interest coverage ratio | n/a |
Cash | ₹5.82m |
Equity | ₹3.86m |
Total liabilities | ₹1.01b |
Total assets | ₹1.02b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 530313's short term assets (₹624.1M) exceed its short term liabilities (₹623.9M).
Long Term Liabilities: 530313's short term assets (₹624.1M) exceed its long term liabilities (₹390.9M).
Debt to Equity History and Analysis
Debt Level: 530313's net debt to equity ratio (14721.8%) is considered high.
Reducing Debt: 530313's debt to equity ratio has increased from 802.1% to 14872.7% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: Whilst unprofitable 530313 has sufficient cash runway for more than 3 years if it maintains its current positive free cash flow level.
Forecast Cash Runway: 530313 is unprofitable but has sufficient cash runway for more than 3 years, due to free cash flow being positive and growing by 22.3% per year.